You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 256 No. 19, November 21, 1986 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorials
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (28)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Prevention of Tuberculosis Among Tuberculin Reactors: Maximizing Benefits, Minimizing Risks

George W. Comstock, MD, DrPH

JAMA. 1986;256(19):2729-2730.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Although an ounce of prevention may often be worth a pound of cure, there is an inherent and unfortunate tendency for prevention to be discouraging. Only in the midst of an epidemic are preventive efforts likely to be visible and dramatic. In most situations, something that is prevented is a nonevent. Individuals can hardly be expected to be aware of nonevents: these can be detected only by statistics. As a consequence, the benefits of prevention are more likely to appeal to our intellect than to our emotions.

Bad effects, on the other hand, are usually readily recognized. Because they are likely to occur in close temporal association with the preventive procedure, they are perceived as resulting from that procedure even when they are merely coincidental. Their emotional effects can be severe, the more so because something bad happened when good was expected.

Prevention of tuberculosis by giving isoniazid to persons . . . [Full Text PDF of this Article]


Author Affiliations

Johns Hopkins University Baltimore



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.